A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts
about
A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@ast
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@en
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@nl
type
label
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@ast
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@en
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@nl
prefLabel
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@ast
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@en
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@nl
P2093
P2860
P1433
P1476
A novel phthalimide derivative ...... myeloma cells and osteoclasts
@en
P2093
Daiju Ichikawa
Fukiko Terada
Hirokazu Shiheido
Hiroshi Yanagawa
Maiko Matsushita
Masashi Hozumi
Noriko Tabata
Taketo Yamada
Yoshie Ozaki
P2860
P304
P356
10.1371/JOURNAL.PONE.0116135
P407
P577
2015-01-01T00:00:00Z